Cardiovascular disease (CVD) remains the number 1 killer across the globe, accounting for around 31 percent of all deaths in 2012.
With this in mind, it is no surprise that cardiology researchers have been particularly focused on identifying ways to stop the deadly disease in its tracks, as well as finding strategies that could enable heart specialists to make earlier and more accurate diagnoses.
New insights this year include the potential for future risk calculations to include genetic markers, and one study even used nanosized porous magnetite frameworks for thrombolytic agents.
In terms of everyday practice, other research findings included confirmation that ST-elevation myocardial infarction (STEMI) mortality can be reduced if emergency medical services are able to get patients directly to centers that offer percutaneous coronary interventions.
Read Entire Article: http://www.medicalnewstoday.com/articles/314590.php